Skip to main content
Equibles
FLGT logo

FLGT · Fulgent Genetics, Inc. · Metrics

Track FLGT — free

Use FLGT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FLGT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.37 +0.27 (+1.34%)
Russell 2000 member Rebalance outlook locked
Market Cap
$553.06M
Shares
27.52M
Volume · Oct 20 28.93K Avg daily vol (3M) 303.58K

FLGT metrics

84 of 116 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.10
Market cap
$553.06M

Price action

20 metrics
Price change (1W)
-6.4%
Price change (30D)
-6.7%
Price change (3M)
+2.5%
Price change (6M)
+24.2%
Price change (YTD)
-23.5%
Price change (1Y)
-11.4%
Trailing year
Price change (5Y)
-75.8%
52-week high
$30.85
52-week low
$13.79
Change from 52-week high
-34.8%
Change from 52-week low
+45.8%
Annualized volatility
60.7%
Annualized volatility (3M)
54.0%
Beta
0.8
RSI (14D)
43.1
Price vs SMA 50
-1.9%
Price vs SMA 200
+2.2%
Avg volume (3M)
303,583
Relative volume
0.7
Average dollar volume
$6.08M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
27.52M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 58.6%
P / book
0.6
reciprocal yield 181.1%
FCF yield
-18.8%
TTM · current market cap
Buyback yield
11.6%
P / FCF
—
P / operating cash flow
—
Earnings yield
-15.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
9.3×
reciprocal yield 10.7%
EV / revenue historical average (5Y)
9.3×
reciprocal yield 10.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
11.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
35.6%
Operating margin
-37.7%
Trailing 12 months
Net margin
-25.9%
Gross profit (TTM)
$115.26M
Operating profit (TTM)
−$122.28M
Net income (TTM)
−$84.01M
Trailing 12 months
Diluted EPS (TTM)
$-0.31
FCF margin
-32.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$10.78
Gross profit per diluted share (TTM)
$3.82
Operating profit per diluted share (TTM)
$-4.08
EBITDA per diluted share (TTM)
$-3.22
Net income per diluted share (TTM)
$-2.82
Operating cash flow per diluted share (TTM)
$-2.78
Free cash flow per diluted share (TTM)
$-3.44
Capital expenditures per diluted share (TTM)
$0.66
R&D per diluted share (TTM)
$1.89
Stock compensation per diluted share (TTM)
$1.24
Book value per share
$35.78

Growth

11 metrics
Revenue growth YoY
+4.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$323.93M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-8.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-19.5%
Revenue CAGR (5Y)
-5.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-8.4%
Return on assets
-7.7%
Debt / equity
—
Current ratio
6.3
EBITDA (TTM)
−$96.46M
Free cash flow (TTM)
−$103.79M
Quick ratio
6.3
Interest coverage
-1,019.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$26.30M
Latest balance sheet
Cash & equivalents
$26.30M
Total assets
$1.09B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$83.70M
Capital expenditures (TTM)
$20.09M
R&D (TTM)
$56.76M
SG&A (TTM)
—
Stock compensation (TTM)
$37.51M
R&D / revenue
17.5%
Stock compensation / revenue
11.6%

Ownership (13F)

3 metrics
13F filers
141
13F filer change QoQ
-17
Institutional ownership
57.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.3%

Short interest

3 metrics
Short interest
8.1%
Latest settlement · 7.2 days to cover
Days to cover
7.2d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$117,132
Insider-sentiment score
38 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1674930 CUSIP 359664109 13F (30d) 13 filings 13 filers Visit website Investor relations